Caption Management, LLC Protagonist Therapeutics, Inc Call Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$18.02 - $29.36 $4.78 Million - $7.8 Million	265,500 Added 1062.0%	290,500 $8.02 Million
Q1 2023 May 15, 2023	BUY	$10.78 - $25.38 $269,500 - $634,500	25,000 New	25,000 $575,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $25.52 $333,938 - $1.21 Million	-47,300 Reduced 7.94%	548,700 $4.34 Million
Q1 2022 May 13, 2022	BUY	$23.34 - $36.08 $13.5 Million - $20.9 Million	579,100 Added 3426.63%	596,000 $14.1 Million
Q4 2021 Feb 11, 2022	SELL	$17.63 - $37.1 $3.89 Million - $8.18 Million	-220,600 Reduced 92.88%	16,900 $577,000
Q3 2021 Nov 12, 2021	BUY	$12.95 - $49.69 $3.08 Million - $11.8 Million	237,500 New	237,500 $4.21 Million

247

56.4M

76.3K

114K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.2B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.